PBK and prostate cancer: In malignant diseases, TOPK has been found to be strongly expressed in various tumors, including melanoma, breast cancer, colorectal cancer, lung cancer, liver cancer, prostate cancer, renal cancer, leukemia, and lymphoma [22].